Rahul

Rahul

Auto-generated profile, based on publicly available information

Rahul


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 May 2025 in Clinical and Experimental Dental Research
Verified
Journal Article
Open access
SSSaravanan SP
Saravanan SP
DFDelfin Lovelina Francis
Delfin Lovelina Francis
HTHarshini Thirumoorthi
Harshini Thirumoorthi
RARahul
Rahul
MRMANISH RATHI
MANISH RATHI
SPShaili Pradhan
Shaili Pradhan
Objectives: The aim of this study was to evaluate the effectiveness of recombinant human bone morphogenetic protein‐2 (rhBMP‐2) coated biphasic calcium phosphate (BCP) in socket preservation in comparison to BCP.Material and Methods: Patients who underwent extraction of maxillary premolars were randomized to receive rhBMP‐2/BCP (n = 15) and BCP alone (n = 15). All sites were primarily closed using a pedicled connective tissue flap. Biopsy was carried out in patients at 3 (n = 10), 6 (n = 10), and 9 (n = 10) months.Results: At 3 months, BMP and non‐BMP groups had 3.17% and 3.12% new bone formation, respectively, and 3.8% and 37.85% of residual grafts, respectively, and 25.86% and 25.99% connective tissue component, respectively. At 6 months, both groups revealed 67.42% and 16.55% essential bone growth, 1.74% and 3.04% of residual graft, and 1.3% and 67% connective tissue component, respectively. At 9 months, the BMP group revealed 93.6% new bone formation, 0.68% residual graft, and 1.9% connective tissue component, while the non‐BMP groups had 23.35% new bone formation, 4.45% residual graft, and 44.06% connective tissue component.Conclusion: This study demonstrated that rhBMP‐2 coated BCP significantly enhanced early graft substitution in socket preservation sites compared to BCP alone. There was a significantly higher percentage of new bone formation in the rhBMP‐2/BCP group both at 6 and 9 months. Additionally, the rhBMP‐2/BCP group exhibited faster resorption of the graft material and earlier maturation of newly formed bone. These findings strongly suggest that rhBMP‐2/BCP can be an effective treatment modality for socket preservation, promoting predictable and accelerated bone regeneration.